Anavex Life Sciences Corp (AVXL)

[RedShoulder]

Biogen's Leqembi, previously known by its scientific name lecanemab has just been approved.

I think this bodes well for A2-73 getting AA and approval, being it is much safer and with better efficacy, it appears AA is coming to A2-73, but first the TLD read out and submission to the FDA.

One of the potential side effects of Biogen's drug is Death. Several cases of death due to brain hemorrhaging has been noted already.

AVXL's A2-73 Blarcamesine with no brain swelling, no brain bleeding' no periodic and expensive brain scans, and no periodic IV infusions, and no deaths.

I think this Biogen's drug approval will make FDA approval for Anavex's A2-73 Blarcamesine as an AA highly likely.